SCHEMBL27195702

SCHEMBL27195702

CN1CCC(c2ccc(C(=O)Nc3cccc4cnccc34)c(S(C)(=O)=O)c2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 2/20 0.48
▸ EPHX2 P34913 1/20 0.47
▸ TRPV1 Q8NER1 4/20 0.45
▸ ROCK2 O75116 9/20 0.41
▸ HDAC3 O15379 1/20 0.41
▸ HDAC4 P56524 1/20 0.41
▸ HDAC1 Q13547 1/20 0.41
▸ HDAC7 Q8WUI4 1/20 0.41
▸ HDAC2 Q92769 1/20 0.41
▸ HDAC10 Q969S8 1/20 0.41
▸ HDAC11 Q96DB2 1/20 0.41
▸ HDAC8 Q9BY41 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ HDAC9 Q9UKV0 1/20 0.41
▸ HDAC5 Q9UQL6 1/20 0.41
▸ CCNE1 P24864 1/20 0.41
▸ CDK2 P24941 1/20 0.41
▸ CDK5 Q00535 1/20 0.41
▸ JAK2 O60674 1/20 0.41
▸ JAK3 P52333 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27195713 0.82 HDAC6 (0.60) CNR1EPHX2TRPV1ROCK2HDAC3
SCHEMBL30863517 0.75 CNR1 (0.51) CNR1EPHX2TRPV1
SCHEMBL27195745 0.75 CNR1 (0.51) CNR1EPHX2TRPV1
Hydrochloric Acid SCHEMBL30863459 0.75 CNR1 (0.57) CNR1EPHX2TRPV1HDAC3HDAC4
SCHEMBL27195727 0.75 CNR1 (0.53) CNR1EPHX2TRPV1HDAC3HDAC4
SCHEMBL27195711 0.75 HDAC6 (0.60) CNR1TRPV1HDAC3HDAC4HDAC1
SCHEMBL27195735 0.73 CNR1 (0.51) CNR1EPHX2TRPV1
SCHEMBL13763336 0.72 TRPV1 (0.60) CNR1TRPV1ROCK2HDAC6CCNE1
SCHEMBL27195721 0.72 SIRT6 (0.55) CNR1EPHX2TRPV1
SCHEMBL27195899 0.72 QDPR (0.52) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581017-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS Biodol Therapeutics (FR) 2025-07-09 — — EP claimed
WO-2024079072-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS BIODOL THERAPEUTICS (FR) 2024-04-18 — — WO claimed
EP-4353712-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS Biodol Therapeutics (FR) 2024-04-17 — — EP claimed
EP-4581017-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS Biodol Therapeutics (FR) 2025-07-09 — — EP disclosed
WO-2024079072-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS BIODOL THERAPEUTICS (FR) 2024-04-18 — — WO disclosed
EP-4353712-A1 NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS Biodol Therapeutics (FR) 2024-04-17 — — EP disclosed
Send feedback